ABOUT SUMMIT THERAPEUTICS; Our Values; Our Programmes; Discuva Platform; Publications; Investor Centre; Press Releases; Reports & Filings; Share Price Data; Contact; Social Media Platforms; Twitter; Linkedin © Summit Therapeutics plc . • Identifying true risk to your business such as stock prices, sales, and bottom-line profits • Hiring differently to support a broad scope of functions, e.g. All quotes are in local exchange time. Summit Therapeutics PLC (SMMT) closed the most recent trading day at $3.68, moving +0.55% from the previous trading session. The 1 year high share price is 0p while the 1 year low share price is currently 0p. Disclaimer; Privacy Policy; Site Map Historical and current end-of-day data provided by FACTSET. Log in to see them here or sign up to get started. There are currently no items in this Watchlist. Stock analysis for Summit Therapeutics Inc (SMMT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Summit Therapeutics Inc. Common Stock (SMMT) Summit Therapeutics Inc. Common Stock. SANS 2021 Endpoint Monitoring in a Dispersed Workforce Survey By Matt Bromiley . Have Watchlists? SUMMIT THERAPEUTICS INC. (NASDAQ:SMMT) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share SUMMIT THERAPEUTICS INC. | Nasdaq: SMMT | Nasdaq ET by Tomi Kilgore. Price trends tend to persist, so it's worth looking at them when it comes to a share like Summit Therapeutics Inc. Over the past six months, the relative strength of its shares against the market has been 73.53%. Missing SQLite Records Analysis By Shafik G. Punja and Ian Whiffin . For the best MarketWatch.com experience, please update to a modern browser. Hence, this presentation focuses on the (TTPs) observed during the event. Earnings Announcement for Period Ending Q1/2021. Cambridge, MA 02142 Create a list of the investments you want to track. Disclaimer; Privacy Policy; Site Map Something went wrong while loading Watchlist. Summit Therapeutics Inc. (“Summit” or the “Company”) Summit Announces Closing of Private Placement of $50 Million Cambridge, MA, November 6, 2020 – Summit (NASDAQ: SMMT) today announces that it … Touch device users, explore by touch or with swipe gestures. The annual ICS Security Summit brings together the industrys top practitioners and leading experts from around the globe to share actionable ideas, methods, and techniques for safeguarding critical infrastructures. What Made H.C. Wainwright Downgrade Summit Therapeutics’ Stock? The Summit Therapeutics 52-week high stock price is 9.00, which is 0.4% above the current share price. Summit Therapeutics PLC (SMMT) Outpaces Stock Market Gains: What You Should Know. It conducts clinical programs focusing on the Clostridium difficile infection (CDI). Chat About SUMM Shares - Stock Quote, Charts, Trade History, Share Chat, Financial Terms Glossary. Summit Therapeutics Inc Ordinary Shares SMMT Morningstar Rating Rating as of Mar 22, 2021. Add all of the ICS Security Summit presentations to your schedule by ... (OpSec). CytoDyn (CYDY) to Report Q4 Earnings: What's in the Cards? When autocomplete results are available use up and down arrows to review and enter to select. In other words, Summit Therapeutics shares trade at around 2x recent earnings. Discover historical prices for SMMT stock on Yahoo Finance. 28, 2018 at 7:51 a.m. The average price target represents a -40.92% upside from the last price of $6.77. Summit Therapeutics is a leader in antibiotic innovation. Summit Therapeutics Plc Share Chat. Is Summit Therapeutics (SMMT) Stock Outpacing Its Medical Peers This Year? SANS and Dragos CTF: March 3 | Free Summit: March 4-5 | Training: March 8-13 | Summit CPE Credits: 12 Co-Chairs: Tim Conway, Robert M. Lee The most comprehensive ICS security event of the year is back — and we’re opening it up to the community! That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). Analysts have given the company’s stock an average 52-week price target of $4, forecast between a low of $4 and high of $4. The stock has traded between $6.15 and $6.43 so far today. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. So far 103,524 shares have traded compared to average volume of 240,082 shares. Summit Therapeutics Inc.(‘Summit’ or the ‘Company’) Cambridge, MA, March 17, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today reports its financial results and provides an update on its operational progress for the fourth quarter and full-year ended December 31, 2020. Latest Whitepapers. Website Designed and Developed by Carr Kamasa Design. Data is currently not available. #ICSSummit. How has Summit Therapeutics' stock price been impacted by Coronavirus? Sorry, no quarterly data is available at this time. SMMT: Get the latest Summit Therapeutics stock price and detailed information including SMMT news, historical charts and realtime prices. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. (SMMT) Nasdaq Listed. Cookie Notice (). Will Ventilator Sales Drive Medtronic's (MDT) Q4 Earnings? Visit a quote page and your recently viewed tickers will be displayed here. Summit Therapeutics PLC (NASDAQ:SMMT) Share Price and News. Copyright © 2021 MarketWatch, Inc. All rights reserved. Latest Share Price and Events Stable Share Price : SMMT is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 15% a week. View today's stock price, news and analysis for Summit Therapeutics Inc. (SMMT). With a 5-year investment, the revenue is expected to be around +320.14%. How has Summit Therapeutics's share price performed over time and what events caused price changes? This browser is no longer supported at MarketWatch. Your current $100 investment may be up to $420.14 in 2026. Company profile page for Summit Therapeutics PLC including stock price, company news, press releases, executives, board members, and contact information One of the bigger stories on AIM this week involved Summit Therapeutics after the drug discoverer and developer secured a funding package of up to US$62million from US authorities. operations, fraud investigations, privacy, legal, marketing, and supply chain • Leveraging vendors as business partners and challenging them to adapt to your specific needs Further, Summit Therapeutics Inc. (SMMT) has a beta value of 0.62, and an average true range (ATR) of 0.95. SUMMIT THERAPEUTICS PLC : News, information and stories for SUMMIT THERAPEUTICS PLC | London Stock Exchange: | London Stock Exchange Summit Therapeutics Inc quote is equal to 5.480 USD at 2021-03-28. The market capitalisation of Summit Therapeutics Plc is … Intraday data delayed at least 15 minutes or per exchange requirements. Director Deals - Summit Therapeutics PLC (SUMM) Robert Duggan, Non Executive Director, sold 33,321,870 shares in the company on the 14th January 2020 at a price of 22.10p. The latest Summit Therapeutics plc Ordinary Shares 1p share price. There are currently 335,873,208 shares in issue and the average daily traded volume is 0 shares. COVID-19 led to a rise of home funerals—this is what they’re like, British Actor Russell Tovey Curates Sotheby’s Contemporary Sale in London, The stock market could double by 2030 because COVID has ‘utterly changed’ the policy environment: analyst, More Democratic senators call for recurring stimulus payments, Stocks pare losses as Dow nears break-even levels, Oil prices settle lower as Suez Canal reopens; focus shifts to OPEC+, Tribune Publishing deal still in flux as challenge to hedge fund Alden takes shape, The worrying reason Japan’s famous cherry blossoms bloomed so early, Summit Therapeutics stock price target suspended at SunTrust Robinson Humphrey, Summit Therapeutics stock price target cut to $4 from $22 at SunTrust RH, Summit Therapeutics downgraded to hold from buy at SunTrust RH, Summit Therapeutics stock fair value estimate cut to $3 from $27 at Janney, Summit Therapeutics downgraded to neutral from buy at Janney, Summit Therapeutics shares down 37% as they resume trading following halt, Summit says will focus on pipeline of new mechanism antibiotics, Summit says it will discontinue trial and take cost-cutting measures, Summit Therapeutics says trial of DMD treatment failed to meet main goals, Summit Therapeutics' stock halted for news pending, Summit Therapeutics started at buy with $27 stock fair value estimate at Janney, Summit Therapeutics shares up 50% premarket, Summit Therapeutics to receive $40 mln in upfront payments, up to $522 mln in milestone payments, Summit Therapeutics and Sarepta in exclusive pact on European rights to DMN treatment, UPDATE: Summit Therapeutics shares plummet 77% after trial of DMD treatment fails to meet main goals, Stocks close lower on jitters over ECB scaling back QE, Sarepta may be the real winner from partnership that lifted Summit Therapeutics stock 50%, Summit Therapeutics stock surges 50% on news of licensing deal with Sarepta, Summit Therapeutics (SMMT) Surges: Stock Moves 7.2% Higher. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Nasdaq 100. Summit Therapeutics PLC (SMMT) Gains As Market Dips: What You Should Know, Summit Therapeutics PLC (SMMT) Gains But Lags Market: What You Should Know, Summit Therapeutics (SMMT) Catches Eye: Stock Jumps 8.9%, Here's Why Momentum Investors Will Love Summit Therapeutics PLC (SMMT), The Zacks Analyst Blog Highlights: DHT, Summit Therapeutics, Sharps Compliance, Frontline and Kala Pharmaceuticals, 5 Stocks Up on Signs of Slowdown in Coronavirus Cases, Top Ranked Momentum Stocks to Buy for April 7th. Summ.l is listed on the London Stock Exchange, trading with ticker code SUMM. Before it's here, it's on the Bloomberg Terminal. The all-time high Summit Therapeutics stock closing price was 16.00 on September 11, 2017. At the current price of $6.87, shares in Summit Therapeutics Inc are trading at 87.09% against their 200 5:25-5:40am EST (10:25- 10:40 UTC) Break. Summit Therapeutics' stock was trading at GBX 20.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Is Summit Therapeutics (SMMT) Outperforming Other Medical Stocks This Year? Summit: March 4-5 | Training: March 8-13. Summit Therapeutics PLC (SMMT) Stock Moves -0.43%: What You Should Know. ABOUT SUMMIT THERAPEUTICS; Our Values; Our Programmes; Discuva Platform; Publications; Investor Centre; Press Releases; Reports & Filings; Share Price Data; Contact; Social Media Platforms; Twitter; Linkedin © Summit Therapeutics plc . Summit Therapeutics Plc operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. Based on our forecasts, a long-term increase is expected, the "SMMT" stock price prognosis for 2026-03-20 is 23.024 USD. Share Prices. Summit Therapeutics Inc (SMMT) stock is trading at $6.32 as of 12:04 PM on Tuesday, Jan 26, an increase of $0.30, or 4.98% from the previous closing price of $6.02. Pentest as a Service with Cobalt By Matt Bromiley . Summit Therapeutics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. … View recent trades and share price information for Summit Therapeutics plc Ordinary Shares 1p Jun. It has a market capitalisation of £0.00, with approximately 0.00 shares in issue. Summit Therapeutics stock price target cut to $4 from $22 at SunTrust RH. The latest closing stock price for Summit Therapeutics as of February 05, 2021 is 8.96. Summit Therapeutics Plc has a 4 week average price of 0p and a 12 week average price of 0p. By using this site you agree to the Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe. This price target is based on 1 analysts offering 12 month price targets for Summit Therapeutics in the last 3 months. Zacks Investment Research - 10 months ago Summit Therapeutics (SMMT) Catches Eye: Stock Jumps 8.9% Summit Therapeutics (SMMT) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes. In depth view into SMMT (Summit Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. ICS Security Summit & Training 2021. ICS Security Summit & Training 2021 - Live Online Virtual, US Eastern | Thu, Mar 4 - Sat, Mar 13, 2021 ... Share. Summit Therapeutics Announces Rights Offering, Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2020, Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating Officer. Privacy Notice, and Website Designed and Developed by Carr Kamasa Design. Volume today is below average. The last closing price for Summit Therapeutics was 20.50p. Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, Summit Announces Closing of Private Placement of $50 Million, Summit Announces Agreement For a Fundraising of approximately $50 Million, One Broadway Subscriber Agreement & Terms of Use, Attack scenarios and examples are shared with the community that consists of the attacks that lead to disruption of the operation. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. View daily, weekly or … United States. Intraday Data provided by FACTSET and subject to terms of use. $6.04.
Trattoria Da Filippo Salzgitter - Speisekarte, Küche Planen Tipps Forum, Hotel Am Berg Esslingen, Armchair Historian Youtube, Wie Viel Watt Braucht Mein Laptop, Obst Aus Dem Alten Land Online Bestellen, Schulische Ausbildung Magdeburg, In Catilinam 1 12 13a, Ipa Lautschrift übersetzer,